Fibroblast growth factor-21 (FGF-21) has been proposed to be associated with NAFLD, but data on its circulating levels in patients with NAFLD are to date conflicting. This evidence concerns the gene FGF21 and metabolic dysfunction-associated steatotic liver disease.